150 related articles for article (PubMed ID: 32332631)
21. Antihyperglycemic drugs use and new-onset atrial fibrillation in elderly patients.
Chen HY; Yang FY; Jong GP; Liou YS
Eur J Clin Invest; 2017 May; 47(5):388-393. PubMed ID: 28369870
[TBL] [Abstract][Full Text] [Related]
22. Thiazolidinediones and the risk of incident strokes in patients with type 2 diabetes: a nested case-control study.
Azoulay L; Schneider-Lindner V; Dell'aniello S; Filion KB; Suissa S
Pharmacoepidemiol Drug Saf; 2010 Apr; 19(4):343-50. PubMed ID: 19998318
[TBL] [Abstract][Full Text] [Related]
23. Metformin and risk of hepatocellular carcinoma in patients with type 2 diabetes.
Tseng CH
Liver Int; 2018 Nov; 38(11):2018-2027. PubMed ID: 29956875
[TBL] [Abstract][Full Text] [Related]
24. The association of pioglitazone and urinary tract disease in type 2 diabetic Taiwanese: bladder cancer and chronic kidney disease.
Lee MY; Hsiao PJ; Yang YH; Lin KD; Shin SJ
PLoS One; 2014; 9(1):e85479. PubMed ID: 24427312
[TBL] [Abstract][Full Text] [Related]
25. Use of thiazolidinediones and the risk of colorectal cancer in patients with diabetes: a nationwide, population-based, case-control study.
Chen SW; Tsan YT; Chen JD; Hsieh HI; Lee CH; Lin HH; Wang JD; Chen PC;
Diabetes Care; 2013 Feb; 36(2):369-75. PubMed ID: 23043163
[TBL] [Abstract][Full Text] [Related]
26. Antihyperglycemic drugs use and new-onset atrial fibrillation: A population-based nested case control study.
Liou YS; Yang FY; Chen HY; Jong GP
PLoS One; 2018; 13(8):e0197245. PubMed ID: 30161122
[TBL] [Abstract][Full Text] [Related]
27. Association between hepatocellular carcinoma and type 2 diabetes mellitus in Italy: potential role of insulin.
Donadon V; Balbi M; Casarin P; Vario A; Alberti A
World J Gastroenterol; 2008 Oct; 14(37):5695-700. PubMed ID: 18837086
[TBL] [Abstract][Full Text] [Related]
28. Association between antiepileptic drugs and hepatocellular carcinoma in patients with epilepsy: a population-based case-control study.
Hung DZ; Lin CL; Li YW; Lin YN; Lee YR; Wang CN; Chen JJ; Lim YP
Brain Behav; 2016 Nov; 6(11):e00554. PubMed ID: 27843704
[TBL] [Abstract][Full Text] [Related]
29. Rosiglitazone reduces breast cancer risk in Taiwanese female patients with type 2 diabetes mellitus.
Tseng CH
Oncotarget; 2017 Jan; 8(2):3042-3048. PubMed ID: 27936468
[TBL] [Abstract][Full Text] [Related]
30. Increased risk of hepatocellular carcinoma in chronic hepatitis B patients with new onset diabetes: a nationwide cohort study.
Fu SC; Huang YW; Wang TC; Hu JT; Chen DS; Yang SS
Aliment Pharmacol Ther; 2015 Jun; 41(11):1200-9. PubMed ID: 25846548
[TBL] [Abstract][Full Text] [Related]
31. Integrating Chinese and Western medicines reduced the incidence of hepatocellular carcinoma in patients with diabetes mellitus: A Taiwanese population-based cohort study.
Lu HL; Su YC; Lin MC; Sun MF; Huang ST
Complement Ther Med; 2020 Mar; 49():102332. PubMed ID: 32147062
[TBL] [Abstract][Full Text] [Related]
32. The impact of type 2 diabetes on the development of hepatocellular carcinoma in different viral hepatitis statuses.
Wang CS; Yao WJ; Chang TT; Wang ST; Chou P
Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2054-60. PubMed ID: 19549812
[TBL] [Abstract][Full Text] [Related]
33. Increased risk of hepatocellular carcinoma in chronic hepatitis C patients with new onset diabetes: a nation-wide cohort study.
Huang YW; Wang TC; Yang SS; Lin SY; Fu SC; Hu JT; Liu CJ; Kao JH; Chen DS
Aliment Pharmacol Ther; 2015 Oct; 42(7):902-11. PubMed ID: 26211742
[TBL] [Abstract][Full Text] [Related]
34. Antidepressant use and hepatocellular carcinoma in patients with hepatitis C who had received interferon therapy: A population-based cohort study.
Chen VC; Lu ML; Yang YH; Weng JC; Chang CC
J Affect Disord; 2019 Jun; 253():147-153. PubMed ID: 31035215
[TBL] [Abstract][Full Text] [Related]
35. The association between thiazolidinediones and hospitalisation for fracture in type 2 diabetic patients: a Taiwanese population-based nested case-control study.
Hsiao FY; Mullins CD
Diabetologia; 2010 Mar; 53(3):489-96. PubMed ID: 19943156
[TBL] [Abstract][Full Text] [Related]
36. Increased risk of gastrointestinal malignancy in patients with diabetes mellitus and correlations with anti-diabetes drugs: a nationwide population-based study in Taiwan.
Chiu CC; Huang CC; Chen YC; Chen TJ; Liang Y; Lin SJ; Chen JW; Leu HB; Chan WL
Intern Med; 2013; 52(9):939-46. PubMed ID: 23648711
[TBL] [Abstract][Full Text] [Related]
37. Pioglitazone and lung cancer risk in Taiwanese patients with type 2 diabetes.
Tseng CH
Diabetes Metab; 2018 Feb; 44(1):77-79. PubMed ID: 28684163
[No Abstract] [Full Text] [Related]
38. Anti-diabetic medications and the risk of hepatocellular cancer: a systematic review and meta-analysis.
Singh S; Singh PP; Singh AG; Murad MH; Sanchez W
Am J Gastroenterol; 2013 Jun; 108(6):881-91; quiz 892. PubMed ID: 23381014
[TBL] [Abstract][Full Text] [Related]
39. Mutual confounding and interactive effects between hepatitis C and hepatitis B viral infections in hepatocellular carcinogenesis: a population-based case-control study in Taiwan.
Sun CA; Farzadegan H; You SL; Lu SN; Wu MH; Wolfe L; Hardy W; Huang GT; Yang PM; Lee H; Chen CJ
Cancer Epidemiol Biomarkers Prev; 1996 Mar; 5(3):173-8. PubMed ID: 8833617
[TBL] [Abstract][Full Text] [Related]
40. [Hepatocellular carcinoma - metformin reduces the risk of type 2 diabetes in a dose-dependent manner].
Z Gastroenterol; 2013 Aug; 51(8):716. PubMed ID: 24298628
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
